Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Michael Halstead. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Michael Halstead har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:ITCI / Intra-Cellular Therapies, Inc. | President | 0 |
Senior V.P., Corp. Development | 0 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Michael Halstead. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Michael Halstead som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-04-02 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
D - Sale to Issuer | −21 307 | 0 | −100,00 | 132,00 | −2 812 524 | ||
2025-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
F - Taxes | −3 757 | 21 307 | −14,99 | 131,24 | −493 069 | 2 796 331 | |
2025-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 7 345 | 25 064 | 41,45 | ||||
2025-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
F - Taxes | −6 718 | 17 719 | −27,49 | 131,19 | −881 334 | 2 324 556 | |
2025-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 13 133 | 24 437 | 116,18 | ||||
2025-03-04 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
F - Taxes | −6 261 | 11 304 | −35,64 | 128,20 | −802 660 | 1 449 173 | |
2025-03-04 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 12 239 | 17 565 | 229,80 | ||||
2025-02-04 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
F - Taxes | −5 691 | 5 326 | −51,66 | 127,00 | −722 757 | 676 402 | |
2025-02-04 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 11 017 | 11 017 | |||||
2024-11-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −5 343 | 0 | −100,00 | 88,92 | −475 100 | |
2024-11-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −13 371 | 5 343 | −71,45 | 88,17 | −1 178 921 | 471 092 |
2024-11-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 18 714 | 18 714 | 36,89 | 690 359 | 690 359 | ||
2024-11-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 648 | 0 | −100,00 | 90,89 | −149 787 | |
2024-11-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −6 116 | 1 648 | −78,77 | 89,63 | −548 177 | 147 710 |
2024-11-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −15 105 | 7 764 | −66,05 | 88,72 | −1 340 116 | 688 822 |
2024-11-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 22 869 | 22 869 | 23,94 | 547 484 | 547 484 | ||
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 238 | 0 | −100,00 | 66,70 | −82 575 | |
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −6 107 | 1 238 | −83,14 | 65,82 | −401 963 | 81 485 |
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 7 345 | 7 345 | |||||
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −220 | 0 | −100,00 | 66,81 | −14 698 | |
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −12 912 | 220 | −98,32 | 66,14 | −854 000 | 14 551 |
2024-03-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 13 132 | 13 132 | |||||
2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −392 | 0 | −100,00 | 70,13 | −27 491 | |
2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −7 215 | 392 | −94,85 | 69,54 | −501 731 | 27 260 |
2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −300 | 7 607 | −3,79 | 68,54 | −20 562 | 521 384 |
2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 7 907 | 7 907 | |||||
2024-02-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −714 | 0 | −100,00 | 67,17 | −47 959 | |
2024-02-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −11 146 | 714 | −93,98 | 66,37 | −739 760 | 47 388 |
2024-02-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 11 860 | 11 860 | |||||
2024-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 486 | 0 | −100,00 | 67,80 | −100 751 | |
2024-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −30 360 | 1 486 | −95,33 | 67,10 | −2 037 156 | 99 711 |
2024-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −18 154 | 31 846 | −36,31 | 66,31 | −1 203 792 | 2 111 708 |
2024-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 3 885 | 50 000 | 8,42 | 23,94 | 93 007 | 1 197 000 | |
2024-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 46 115 | 46 115 | 12,73 | 587 044 | 587 044 | ||
2023-11-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −41 067 | 0 | −100,00 | 54,01 | −2 218 029 | |
2023-11-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −8 933 | 41 067 | −17,87 | 53,37 | −476 754 | 2 191 746 |
2023-11-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 34 836 | 50 000 | 229,73 | 12,73 | 443 462 | 636 500 | |
2023-11-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 15 164 | 15 164 | 15,47 | 234 587 | 234 587 | ||
2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −476 | 0 | −100,00 | 44,15 | −21 015 | |
2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −6 868 | 476 | −93,52 | 44,99 | −308 991 | 21 415 |
2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 7 344 | 7 344 | |||||
2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −2 500 | 0 | −100,00 | 42,52 | −106 300 | |
2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −14 208 | 2 500 | −85,04 | 43,20 | −613 786 | 108 000 |
2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 16 708 | 16 708 | |||||
2023-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −7 906 | 0 | −100,00 | 47,03 | −371 819 | |
2023-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 7 906 | 7 906 | |||||
2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 49,60 | −4 960 | |
2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 100 | 100 | −91,67 | 48,68 | −53 548 | 4 868 |
2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −643 | 1 200 | −34,89 | 47,23 | −30 369 | 56 676 |
2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −9 296 | 1 843 | −83,45 | 46,56 | −432 822 | 85 810 |
2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 11 139 | 11 139 | |||||
2022-12-02 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −22 796 | 0 | −100,00 | 53,48 | −1 219 130 | |
2022-12-02 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −27 204 | 22 796 | −54,41 | 53,94 | −1 467 384 | 1 229 616 |
2022-12-02 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 50 000 | 50 000 | 15,47 | 773 500 | 773 500 | ||
2022-03-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 22 034 | 22 034 | |||||
2022-03-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 17 916 | 17 916 | |||||
2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 188 | 0 | −100,00 | 51,62 | −216 185 | |
2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 718 | 4 188 | −47,03 | 52,38 | −194 749 | 219 367 |
2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −7 906 | 15 813 | −33,33 | ||||
2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 7 906 | 7 906 | |||||
2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 550 | 0 | −100,00 | 54,98 | −250 159 | |
2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −6 589 | 4 550 | −59,15 | 55,69 | −366 941 | 253 390 |
2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −11 139 | 11 139 | −50,00 | ||||
2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 11 139 | 11 139 | |||||
2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 380 | 0 | −100,00 | 40,12 | −175 726 | |
2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −12 755 | 4 380 | −74,44 | 40,81 | −520 532 | 178 748 |
2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −2 504 | 17 135 | −12,75 | 41,74 | −104 517 | 715 215 |
2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −19 639 | 0 | −100,00 | ||||
2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 19 639 | 19 639 | |||||
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −63 717 | 0 | −100,00 | ||||
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −88 146 | 0 | −100,00 | ||||
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −25 000 | 0 | −100,00 | ||||
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 344 | 0 | −100,00 | 44,87 | −194 915 | |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −8 690 | 4 344 | −66,67 | 45,74 | −397 481 | 198 695 |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −36 434 | 13 034 | −73,65 | 46,87 | −1 707 662 | 610 904 |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −104 775 | 49 468 | −67,93 | 47,84 | −5 012 436 | 2 366 549 |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −22 620 | 154 243 | −12,79 | 48,62 | −1 099 784 | 7 499 295 |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 63 717 | 176 863 | 56,31 | 15,73 | 1 002 268 | 2 782 055 | |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 88 146 | 113 146 | 352,58 | 17,57 | 1 548 725 | 1 987 975 | |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 25 000 | 25 000 | 13,86 | 346 500 | 346 500 | ||
2021-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 23 719 | 23 719 | |||||
2021-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 18 714 | 18 714 | |||||
2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 100 | 0 | −100,00 | 38,91 | −42 801 | |
2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −10 039 | 1 100 | −90,12 | 39,28 | −394 332 | 43 208 |
2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −11 139 | 22 278 | −33,33 | ||||
2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 11 139 | 11 139 | |||||
2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 936 | 0 | −100,00 | 31,65 | −61 274 | |
2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −17 702 | 1 936 | −90,14 | 32,07 | −567 703 | 62 088 |
2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −19 638 | 19 639 | −50,00 | ||||
2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 19 638 | 19 638 | |||||
2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 174 | 0 | −100,00 | 30,94 | −98 204 | |
2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −12 986 | 3 174 | −80,36 | 31,39 | −407 631 | 99 632 |
2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −16 160 | 0 | −100,00 | ||||
2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 16 160 | 16 160 | |||||
2020-11-19 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −75 000 | 25 000 | −75,00 | ||||
2020-11-19 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | −3 761 | 0 | −100,00 | 27,95 | −105 120 | ||
2020-11-19 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | −75 664 | 3 761 | −95,26 | 27,60 | −2 088 326 | 103 804 | |
2020-11-19 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 75 000 | 79 425 | 1 694,92 | 13,86 | 1 039 500 | 1 100 830 | |
2020-02-20 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 33 417 | 33 417 | |||||
2020-02-20 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 26 754 | 26 754 | |||||
2020-01-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
J - Other | −3 809 | 4 425 | −46,26 | 23,61 | −89 930 | 104 474 | |
2020-01-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 8 043 | 8 234 | 4 210,99 | ||||
2020-01-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −19 638 | 191 | −99,04 | 26,16 | −513 730 | 4 997 |
2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −19 638 | 39 277 | −33,33 | ||||
2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 19 638 | 19 829 | 10 281,68 | ||||
2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −17 513 | 191 | −98,92 | 30,46 | −533 446 | 5 818 |
2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 945 | 17 704 | −18,22 | 29,80 | −117 561 | 527 579 |
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −16 160 | 16 160 | −50,00 | ||||
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −5 298 | 0 | −100,00 | ||||
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 16 160 | 21 649 | 294,41 | ||||
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 5 298 | 5 489 | 2 773,82 | ||||
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −25 | 191 | −11,57 | 34,30 | −858 | 6 551 |
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 200 | 216 | −84,75 | 33,23 | −39 876 | 7 178 |
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 959 | 1 416 | −77,79 | 32,43 | −160 820 | 45 921 |
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 623 | 6 375 | −20,29 | 31,83 | −51 660 | 202 916 |
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 7 807 | 7 998 | 4 087,43 | ||||
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 58 915 | 58 915 | |||||
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 80 951 | 80 951 | |||||
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 108 | 191 | −94,21 | 12,42 | −38 601 | 2 372 |
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −3 108 | 0 | −100,00 | ||||
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −5 398 | 3 299 | −62,07 | 11,80 | −63 696 | 38 928 |
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −16 060 | 8 697 | −64,87 | 11,34 | −182 120 | 98 624 |
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 3 108 | 24 757 | 14,36 | ||||
2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −16 160 | 32 320 | −33,33 | ||||
2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −5 298 | 5 298 | −50,00 | ||||
2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 16 160 | 21 649 | 294,41 | ||||
2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 5 298 | 5 489 | 2 773,82 | ||||
2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −7 807 | 191 | −97,61 | 11,09 | −86 580 | 2 118 |
2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 7 807 | 7 998 | 4 087,43 | ||||
2018-01-24 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −25 500 | 191 | −99,26 | 18,03 | −459 765 | 3 444 |
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 560 | 25 691 | −5,72 | 17,49 | −27 284 | 449 336 |
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −3 108 | 3 108 | −50,00 | ||||
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −2 660 | 27 251 | −8,89 | 15,75 | −41 895 | 429 203 |
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 3 108 | 29 911 | 11,60 | ||||
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 48 480 | 48 480 | |||||
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 65 164 | 65 164 | |||||
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −5 297 | 10 596 | −33,33 | ||||
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 5 297 | 26 803 | 24,63 | ||||
2017-01-09 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 601 | 21 506 | −6,93 | 16,55 | −26 497 | 355 924 |
2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −3 107 | 6 216 | −33,33 | ||||
2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 3 107 | 23 107 | 15,54 | ||||
2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 15 893 | 15 893 | |||||
2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 63 717 | 63 717 | |||||
2016-01-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 9 323 | 9 323 | |||||
2016-01-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 39 307 | 39 307 | |||||
2015-01-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 88 146 | 88 146 | |||||
2014-11-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
P - Purchase | 13 000 | 20 000 | 185,71 | 15,47 | 201 110 | 309 400 | |
2014-11-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
P - Purchase | 7 000 | 7 000 | 15,21 | 106 470 | 106 470 | ||
2014-07-31 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 100 000 | 100 000 | |||||
2013-10-01 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
D - Sale to Issuer | −36 370 | 0 | −100,00 | ||||
2013-10-01 |
|
4 | WCRX |
Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share |
D - Sale to Issuer | −53 050 | 0 | −100,00 | ||||
2013-10-01 |
|
4 | WCRX |
Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share |
D - Sale to Issuer | −26 050 | 0 | −100,00 | ||||
2013-10-01 |
|
4 | WCRX |
Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share |
D - Sale to Issuer | −9 280 | 0 | −100,00 | ||||
2013-10-01 |
|
4 | WCRX |
Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share |
D - Sale to Issuer | −10 340 | 0 | −100,00 | ||||
2013-10-01 |
|
4 | WCRX |
Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share |
D - Sale to Issuer | −6 203 | 0 | −100,00 | ||||
2013-10-01 |
|
4 | WCRX |
Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share |
D - Sale to Issuer | −1 463 | 0 | −100,00 | ||||
2013-10-01 |
|
4 | WCRX |
Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share |
D - Sale to Issuer | −6 790 | 0 | −100,00 | ||||
2013-10-01 |
|
4 | WCRX |
Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share |
D - Sale to Issuer | −1 945 | 0 | −100,00 | ||||
2013-10-01 |
|
4 | WCRX |
Warner Chilcott plc
Performance Restricted Share Units |
D - Sale to Issuer | −15 020 | 0 | −100,00 | ||||
2013-10-01 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
D - Sale to Issuer | −15 470 | 36 370 | −29,84 | ||||
2013-07-02 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
S - Sale | −366 | 51 840 | −0,70 | 19,88 | −7 276 | 1 030 579 | |
2013-03-01 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
S - Sale | −1 747 | 52 206 | −3,24 | 13,46 | −23 521 | 702 886 | |
2013-02-21 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
S - Sale | −419 | 53 953 | −0,77 | 14,53 | −6 087 | 783 813 | |
2013-02-15 |
|
4 | WCRX |
Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share |
A - Award | 53 050 | 53 050 | |||||
2013-02-15 |
|
4 | WCRX |
Warner Chilcott plc
Performance Restricted Share Units |
A - Award | 15 020 | 15 020 | |||||
2013-02-15 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
A - Award | 15 470 | 54 372 | 39,77 | ||||
2013-02-04 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
S - Sale | −998 | 38 902 | −2,50 | 14,18 | −14 150 | 551 560 | |
2013-01-31 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
S - Sale | −320 | 39 900 | −0,80 | 13,38 | −4 283 | 534 026 | |
2013-01-23 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
S - Sale | −488 | 40 220 | −1,20 | 13,50 | −6 588 | 542 966 | |
2012-10-01 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
S - Sale | −77 | 40 708 | −0,19 | 13,55 | −1 043 | 551 593 | |
2012-07-02 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
S - Sale | −355 | 40 785 | −0,86 | 17,96 | −6 376 | 732 499 | |
2012-03-02 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
S - Sale | −725 | 41 140 | −1,73 | 17,00 | −12 324 | 699 347 | |
2012-02-23 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
S - Sale | −409 | 41 865 | −0,97 | 16,82 | −6 880 | 704 274 | |
2012-02-02 |
|
4 | WCRX |
Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share |
A - Award | 26 050 | 26 050 | |||||
2012-02-02 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
A - Award | 20 790 | 42 274 | 96,77 | ||||
2012-01-31 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
S - Sale | −320 | 21 484 | −1,47 | 16,45 | −5 265 | 353 448 | |
2012-01-24 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
S - Sale | −487 | 21 804 | −2,18 | 17,32 | −8 435 | 377 634 | |
2012-01-12 |
|
4 | WCRX |
Warner Chilcott plc
Ordinary shares, par value $0.01 per share |
S - Sale | −452 | 22 291 | −1,99 | 16,66 | −7 531 | 371 379 |